Author Correction: The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis

AI Insight

This article is an Author Correction notice published in Nature, referring to a study examining the role of the AIM2 inflammasome in the context of clonal haematopoiesis and its contribution to atherosclerosis progression. The original research investigated how somatic mutations leading to clonal haematopoiesis activate the AIM2 inflammasome pathway, thereby worsening atherosclerotic cardiovascular disease. The correction notice indicates that post-publication amendments were necessary, though the specific nature of the corrections is not detailed in the available content.

Why it matters

Clonal haematopoiesis is an increasingly recognized risk factor for cardiovascular disease, and identifying the AIM2 inflammasome as a mechanistic driver opens potential therapeutic avenues for reducing atherosclerosis risk in affected individuals.